Cardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes

dc.contributor.advisorNtusi, Ntobeko A B
dc.contributor.authorEmhemed, Mohamed
dc.date.accessioned2023-02-15T12:08:11Z
dc.date.available2023-02-15T12:08:11Z
dc.date.issued2022
dc.date.updated2023-02-15T12:07:48Z
dc.description.abstractIntroduction: Sarcoidosis is an inflammatory disorder that affects multiple systems. On histologic examination, sarcoidosis is defined by the production of non-caseating granulomas. Cardiac sarcoidosis (CS) is common, occurring in 20% or more of patients with systemic sarcoidosis, but because many people with CS may have nonspecific clinical manifestations or subclinical disease, the real extent of the disease prevalence is uncertain and possibly underestimated. Methods: Medical records of patients with CS diagnosed by cardiovascular magnetic resonance (CMR) were selected for inclusion into this study. We identified patients with a diagnosis of CS by CMR between March 2005 and January 2018 at Groote Schuur Hospital, Cape Town, South Africa and included into the South African Cardiovascular Magnetic Resonance (SA-CMR) registry. The demographics, clinical profile, and outcomes of patients diagnosed with CS via CMR were summarised utilising proportions, medians with interquartile ranges (IQRs), and means with standard deviations (SDs), as appropriate. Fisher's exact test was utilised to compare proportions, while T tests and Mann-Whitney U-tests were utilised to compare means and medians, respectively. Statistical Package for Social Sciences (version 26) program was used to analyse the data. Results: Medical records of 35 patients with a confirmed diagnosis of CS using CMR during the study period were identified. There were 21 (60%) males, and a male: female ratio of 1.5:1. The mean age of study participants was 50.3 ± 11 years. Most patients (84%) were overweight and obese, and comorbidities included hypertension (9%) and diabetes mellitus (3%). Nearly a quarter (23%) of patients presented with complete heart block and a third (31%) had ventricular tachycardia (VT) as the initial presentation. Half (54%) of patients had a permanent pacemaker or implantable cardioverter defibrillator implanted. A third (34%) of patients had evidence of acute myocardial oedema on T2-weighted imaging and T2 mapping, and 91% of subjects had evidence of focal fibrosis/infiltration on late gadolinium enhancement (LGE). Most patients (80%) had normal pericardial thickness and small pericardial effusions (< 1 cm) were noted in 49%. Extra-cardiac findings of sarcoidosis were characterised by hilar lymphadenopathy and pulmonary interstitial involvement (49%) and pleural effusions (11%). There were no deaths during the study period and median follow-up of 7 years. Conclusions: Sarcoidosis is a granulomatous systemic multiorgan condition that is a challenge to diagnose and manage in many settings. The availability of CMR has made it possible to diagnose CS noninvasively. We show that in our setting CS is characterised by oedema in a third of patients and evidence of LGE in almost all patients. Heart block and VT are common presentations; however, the prognosis is good with modern device therapies once the diagnosis has been made.
dc.identifier.apacitationEmhemed, M. (2022). <i>Cardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes</i>. (). ,Faculty of Health Sciences ,Department of Medicine. Retrieved from http://hdl.handle.net/11427/36927en_ZA
dc.identifier.chicagocitationEmhemed, Mohamed. <i>"Cardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes."</i> ., ,Faculty of Health Sciences ,Department of Medicine, 2022. http://hdl.handle.net/11427/36927en_ZA
dc.identifier.citationEmhemed, M. 2022. Cardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes. . ,Faculty of Health Sciences ,Department of Medicine. http://hdl.handle.net/11427/36927en_ZA
dc.identifier.ris TY - Master Thesis AU - Emhemed, Mohamed AB - Introduction: Sarcoidosis is an inflammatory disorder that affects multiple systems. On histologic examination, sarcoidosis is defined by the production of non-caseating granulomas. Cardiac sarcoidosis (CS) is common, occurring in 20% or more of patients with systemic sarcoidosis, but because many people with CS may have nonspecific clinical manifestations or subclinical disease, the real extent of the disease prevalence is uncertain and possibly underestimated. Methods: Medical records of patients with CS diagnosed by cardiovascular magnetic resonance (CMR) were selected for inclusion into this study. We identified patients with a diagnosis of CS by CMR between March 2005 and January 2018 at Groote Schuur Hospital, Cape Town, South Africa and included into the South African Cardiovascular Magnetic Resonance (SA-CMR) registry. The demographics, clinical profile, and outcomes of patients diagnosed with CS via CMR were summarised utilising proportions, medians with interquartile ranges (IQRs), and means with standard deviations (SDs), as appropriate. Fisher's exact test was utilised to compare proportions, while T tests and Mann-Whitney U-tests were utilised to compare means and medians, respectively. Statistical Package for Social Sciences (version 26) program was used to analyse the data. Results: Medical records of 35 patients with a confirmed diagnosis of CS using CMR during the study period were identified. There were 21 (60%) males, and a male: female ratio of 1.5:1. The mean age of study participants was 50.3 ± 11 years. Most patients (84%) were overweight and obese, and comorbidities included hypertension (9%) and diabetes mellitus (3%). Nearly a quarter (23%) of patients presented with complete heart block and a third (31%) had ventricular tachycardia (VT) as the initial presentation. Half (54%) of patients had a permanent pacemaker or implantable cardioverter defibrillator implanted. A third (34%) of patients had evidence of acute myocardial oedema on T2-weighted imaging and T2 mapping, and 91% of subjects had evidence of focal fibrosis/infiltration on late gadolinium enhancement (LGE). Most patients (80%) had normal pericardial thickness and small pericardial effusions (< 1 cm) were noted in 49%. Extra-cardiac findings of sarcoidosis were characterised by hilar lymphadenopathy and pulmonary interstitial involvement (49%) and pleural effusions (11%). There were no deaths during the study period and median follow-up of 7 years. Conclusions: Sarcoidosis is a granulomatous systemic multiorgan condition that is a challenge to diagnose and manage in many settings. The availability of CMR has made it possible to diagnose CS noninvasively. We show that in our setting CS is characterised by oedema in a third of patients and evidence of LGE in almost all patients. Heart block and VT are common presentations; however, the prognosis is good with modern device therapies once the diagnosis has been made. DA - 2022 DB - OpenUCT DP - University of Cape Town KW - medicine LK - https://open.uct.ac.za PY - 2022 T1 - Cardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes TI - Cardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes UR - http://hdl.handle.net/11427/36927 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/36927
dc.identifier.vancouvercitationEmhemed M. Cardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes. []. ,Faculty of Health Sciences ,Department of Medicine, 2022 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/36927en_ZA
dc.language.rfc3066eng
dc.publisher.departmentDepartment of Medicine
dc.publisher.facultyFaculty of Health Sciences
dc.subjectmedicine
dc.titleCardiac sarcoidosis defined by cardiovascular magnetic resonance: patient characteristics and outcomes
dc.typeMaster Thesis
dc.type.qualificationlevelMasters
dc.type.qualificationlevelMMed
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
thesis_hsf_2022_emhemed mohamed.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Collections